Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 3—March 2005
Research

Malaria Risk in Travelers

Helena Hervius Askling*†, Jenny Nilsson*†, Anders Tegnell*, Ragnhild Janzon*, and Karl Ekdahl*‡Comments to Author 
Author affiliations: *Swedish Institute for Infectious Disease Control, Stockholm, Sweden; †Karolinska University Hospital, Stockholm, Sweden; ‡Karolinska Institute, Stockholm, Sweden

Main Article

Table 5

Malaria risk for officially reported travelers compared to incidence (as reported to WHO, 2001*) and estimated rate (based on TDB) in corresponding region†

Data from in-flight/visa Data from TDB
Country
Y
Cases
No. of travelers
Risk/100,000
No. of 
travelers
Risk/100,000
95% CI
Data from WHO
incidence/100,000
Thailand 2001–2002 9 453,000 2.0 435,000 2.1 1.0–4.2 100
India 2001–2003 7 48,687 14.4 192
Indian subcontinent 2001–2003 25‡ 72,000 35 17-71
Gambia 1997–2003 79 31,242 253 10.096
West Africa 1997–2003 242§ 80,000 302 196–468
South Africa 1997–2001 3 98,886 3 61
Southern Africa 1997–2001 63¶ 128,000 49 32–76

*Information from The Gambia was from 1999.
†WHO, World Health Organization (15);TDB, Swedish Travel and Tourist Database; CI, confidence intervals.
‡7 cases from India, 13 cases from Afghanistan, and 5 cases from Pakistan.
§6 cases from Benin, 4 cases from Burkina Faso, 31 cases from Ivory Coast, 79 cases from The Gambia, 65 cases from Ghana, 11 cases from Guinea, 5 cases from Guinea-Bissau, 11 cases from Liberia, 3 cases from Mali, 11 cases from Senegal, 11 cases from Sierra Leone, and 5 cases from Togo.
¶14 cases from Angola, 5 cases in Madagascar, 8 cases from Malawi, 13 cases from Mozambique, 3 cases from Namibia, 3 cases from South Africa, 7 cases from Zambia, and 10 cases from Zimbabwe.

Main Article

References
  1. World Tourism Organization. World tourism barometer. 2004;2:1–22.
  2. Jelinek  T, Schulte  C, Behrens  R, Grobusch  MP, Coulaud  JP, Bisoffi  Z, Imported falciparum malaria in Europe: sentinel surveillance data from the European Network on Surveillance of Imported Infectious Diseases. Clin Infect Dis. 2002;34:5726. DOIPubMedGoogle Scholar
  3. Toovey  S, Jamieson  A. Rolling back malaria: how well is Europe doing? Travel Med Infect Dis. 2003;1:16775. DOIPubMedGoogle Scholar
  4. Ekdahl  K, ed. Communicable diseases in Sweden 2002. The yearly report of the Department of Epidemiology. Stockholm: Swedish Institute for Infectious Disease Control; 2003.
  5. Phillips-Howard  PA, Radalowicz  A, Mitchell  J, Bradely  DJ. Risk of malaria in British residents returning from malarious areas. BMJ. 1990;300:499503. DOIPubMedGoogle Scholar
  6. Hill  DR, Behrens  RH, Bradley  DJ. The risk of malaria in travelers to Thailand. Trans R Soc Trop Med Hyg. 1996;90:6801. DOIPubMedGoogle Scholar
  7. Lobel  HO, Phillips-Howard  PA, Brandling-Bennett  AD, Steffen  R, Campbell  CC, Huong  AY. Malaria incidence and prevention among European and North American travelers to Kenya. Bull World Health Organ. 1990;68:20915.PubMedGoogle Scholar
  8. Steffen  R, Heusser  R, Mäckler  R, Bruppacher  R, Naef  U, Chen  D, Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions and efficacy. Bull World Health Organ. 1990;68:31322.PubMedGoogle Scholar
  9. World Health Organization. Development of recommendations for the protection of short-stay travelers to malaria endemic areas. Memorandum from two WHO meetings. Bull World Health Organ. 1988;66:17796.PubMedGoogle Scholar
  10. Ryan  ET, Kain  KC. Health advice and immunization for travelers. N Engl J Med. 2000;342:171625. DOIPubMedGoogle Scholar
  11. Spira  AM. Assessment of travelers who return home ill. Lancet. 2003;361:145969. DOIPubMedGoogle Scholar
  12. Health Canada. 2000. Canadian recommendations for the prevention and treatment of malaria among international travelers. (cited 13 Jan 2005). Available from http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/00vol26/26s2/index.html
  13. Kofoed  K, Petersen  E. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefoquine, and atovaquone plus proguanil in travelers fron Denmark. J Travel Med. 2003;10:1504. DOIPubMedGoogle Scholar
  14. Swedish Travel and Tourist Data Base. TDB. Resurs AB, Sweden. (cited 24 Jan 2004). Available from http://www.resursab.se/
  15. World Health Organization. Global atlas of infectious diseases: Global Roll Back Malaria Online Database. (cited 24 Jan 2004). Available from http://www.who.int/GlobalAtlas/DataQuery/quickQuery.asp
  16. World Health Organization. Countries and territories with malarious areas. Geographical distribution. International Travel and Health 2003. (cited 24 Jan 2004). Available from http://www.who.int/ith/chapter07_01.html
  17. Jansson  A, Arneborn  M, Ekdahl  K. Sevsitivity of case reporting in the Swedish statutory surveillance of communicable diseases 1998–2002. Epidemiol Infect. In press.PubMedGoogle Scholar
  18. Muehlberger  N, Jelinek  T, Schlipkoeter  U, von Sonnenburg  F, Nothdurft  HD. Effectiveness of chemoprophylaxis and other determinants of malaria in travellers to Kenya. Trop Med Int Health. 1998;3:35763. DOIPubMedGoogle Scholar
  19. Mölle  I, Christensen  KL, Hansen  PS, Dragsted  UB, Aarup  M, Buhl  MR. Use of medical chemoprophylaxis and antimosquito precautions in Danish malaria patients and their traveling companions. J Travel Med. 2000;7:2538. DOIPubMedGoogle Scholar
  20. Schlagenhauf-Lawlor  P, ed. Travelers’ malaria. Hamilton, Ontario: BC Decker Inc; 2001.
  21. Bacaner  N, Stauffer  B, Boulware  DR, Walker  PF, Keystone  JS. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA. 2004;291:285664. DOIPubMedGoogle Scholar
  22. Brunvatne  R, Blystad  H, Hoel  T. Health hazards for immigrants when travelling to their home countries. Tidsskr Nor Laegeforen. 2002;122:156872.PubMedGoogle Scholar
  23. Blystad  H. Import of malaria to Norway 1989–98. Tidsskr Nor Laegeforen. 2000;120:16537.PubMedGoogle Scholar
  24. Muhlberger  N, Jelinek  T, Gascon  J, Probst  M, Zoller  T, Schunk  M, Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J. 2004;3:17. DOIPubMedGoogle Scholar
  25. Swedish Institute for Infectious Disease Control. Annual epidemiological report 2003. (cited 24 Jan 2004). Available from http//www.smittskyddsinstitutet.se
  26. Trape  JF, Rogier  C. Combating malaria morbidity and mortality by reducing transmission. Parasitol Today. 1996;12:23640. DOIPubMedGoogle Scholar
  27. Beier  JC, Killeen  GF, Githure  JI. Short report: entomologic inoculation rates and Plasmodium falciparum prevalence in Africa. Am J Trop Med Hyg. 1999;61:10913.PubMedGoogle Scholar
  28. Mapping malaria risk in Africa/Atlas du risque de la malaria en Afrique. Gambia malaria prevalence model. March 2002. (cited 24 Jan 2004). Available from http://www.mara.org.za/maps.htm
  29. Breman  JG. The ears of the hippopotamus: manifestations, determinants and estimates of the malaria burden. Am J Trop Med Hyg. 2001;64(1–2 Suppl):1–11.

Main Article

Page created: April 25, 2012
Page updated: April 25, 2012
Page reviewed: April 25, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external